Published online September 30, 2005
PEDIATRICS Vol. 116 No. 4 October 2005, pp. 901-907 (doi:10.1542/peds.2004-2377)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mitchell, W. G.
Right arrow Articles by Rodriguez, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitchell, W. G.
Right arrow Articles by Rodriguez, J.
Related Collections
Right arrow Neurology & Psychiatry
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Longitudinal Neurodevelopmental Evaluation of Children With Opsoclonus-Ataxia

Wendy G. Mitchell, MD*,{ddagger}, Virdette L. Brumm, PhD*,{ddagger}, Colleen G. Azen, MS§, Kirsten E. Patterson, MA, OTR||, Sonia K. Aller, PhD, CCC and Jenny Rodriguez*

* Division of Neurology
§ General Clinical Research Center
|| Physical and Occupational Therapy
University of Southern California University Affiliated Program at Childrens Hospital Los Angeles
{ddagger} Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, California

Objective.We previously reported on children with opsoclonus-ataxia and found pervasive neurodevelopmental deficits, years after onset, without a clear relationship to treatment modality or timing of treatment. A significant negative correlation of functional status with age at testing raised a question of whether opsoclonus-ataxia is a progressive encephalopathy. We attempted to answer this question with serial testing. In addition, we examined the relationship between clinical course and developmental outcome.

Methods.Thirteen of 17 children with opsoclonus-ataxia, all with neuroblastoma, who were previously reported were reevaluated a second time 2 to 4 years after the initial assessment. One subject who lived out of state was partially reevaluated and is included. Five new subjects (2 with neuroblastoma and 3 without) were also enrolled. Each was evaluated twice at a minimum interval of 1 year between sessions. Intercurrent medical course was recorded, emphasizing medication and relapse history. Cognitive, adaptive behavior, academic, speech and language, and motor abilities were assessed.

Results.For the group as a whole, overall standardized, age-adjusted cognitive scores improved. Generally, younger subjects' cognitive and adaptive behavior scores improved more than older subjects. Although all subjects had gains in speech, language, and motor function, some progressed at a slow pace, and in some instances, standard scores dropped. There was a striking influence of clinical course. Although initial presentation was severe and all subjects required high doses of corticosteroids or corticotropin, 5 had a monophasic course and were able to be weaned from treatment without relapses. Fourteen had multiple relapses over the years, generally with reduction of medication or intercurrent illnesses. Of the 5 children with monophasic course, 4 are currently functioning in the average range with a full-scale IQ of ≥90 and age-appropriate academic and adaptive skills.

Conclusions.The results continue to raise concern that opsoclonus-ataxia is sometimes a progressive encephalopathy. A minority of children with opsoclonus-ataxia have a monophasic course. Despite initial severity of symptoms, these children may have a more benign prognosis. For the majority of children with opsoclonus-ataxia, the course includes multiple relapses and requires prolonged treatment. Developmental sequelae are significant in these children with chronic course.


Key Words: opsoclonus • neuroblastoma • outcome • development • paraneoplastic syndromes • ataxia

Abbreviations: ACTH, corticotropin • IVIg, intravenous immunoglobulin • VABS, Vineland Adaptive Behavior Scales • DQ, developmental quotient


Accepted Jan 13, 2005.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Child NeurolHome page
M. R. Pranzatelli, E. D. Tate, A. L. Travelstead, C. A. Baumgardner, N. V. Gowda, S. N. Halthore, P. Kerstan, B. D. Kossak, W. G. Mitchell, and J. W. Taub
Insights on Chronic-Relapsing Opsoclonus-Myoclonus From a Pilot Study of Mycophenolate Mofetil
J Child Neurol, March 1, 2009; 24(3): 316 - 322.
[Abstract] [PDF]


Home page
JCOHome page
K. A. P. Schultz, K. K. Ness, J. Whitton, C. Recklitis, B. Zebrack, L. L. Robison, L. Zeltzer, and A. C. Mertens
Behavioral and Social Outcomes in Adolescent Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
J. Clin. Oncol., August 20, 2007; 25(24): 3649 - 3656.
[Abstract] [Full Text] [PDF]